All European Centre for Disease Prevention and Control articles
-
NewsDespite progress towards eliminating hepatitis in Europe, gaps in prevention measures keep 2030 targets out of reach
Viral hepatitis remains a significant public health challenge across Europe but childhood vaccination against hepatitis B and provision of harm reduction services show results.
-
NewsDrug-resistant gonorrhea on the rise in Europe, ECDC warns
An increasing number of European countries have detected gonococcal strains resistant to the antibiotic ceftriaxone, the first-line drug to treat gonorrhea infection.
-
NewsEurope advances genomic surveillance of CCRE with landmark multi-country study
New survey results provide the most comprehensive genomic picture to date of carbapenem- and/or colistin-resistant Enterobacterales (CCRE) across hospitals in Europe.
-
NewsAndes hantavirus outbreak: ECDC working on the frontline to support EU Member States
Genomic information also shows that the virus involved in the outbreak is similar to Andes viruses already known to circulate in South America, and is not a new variant. There is currently no evidence that this variant spreads more easily or causes more severe disease than other Andes viruses.
-
NewsThree European countries reach 90% HPV vaccination target as Europe steps up action on cancer prevention
All EU/EEA countries now recommend HPV vaccination for adolescent girls and boys as part of their immunisation programmes, marking a major step forward in Europe’s’ cancer prevention efforts. Iceland, Portugal and Norway have reached the target of 90% HPV vaccination coverage among girls by the age of 15.
-
NewsBetween 2.4 and 4.1 million people estimated to be living with chronic hepatitis B infection in Europe
Chronic hepatitis B is substantially prevalent across the European Union and European Economic Area (EU/EEA), affecting an estimated 0.7% of the population in the region in 2022, according to a new study.
-
NewsEuropean Region misses 1 in 5 TB cases: WHO Europe and ECDC publish new joint surveillance report
The European Region continues to fall short of regional and global End TB milestones on two fronts: a persistent detection challenge, with one in five TB cases going undiagnosed or unreported, and drug-resistance levels that remain far higher than in other regions.
-
NewsAntimicrobial resistance in foodborne bacteria remains a public health concern in Europe
Antimicrobial resistance (AMR) in common foodborne bacteria such as Salmonella and Campylobacter continues to be a public health concern across Europe, according to a new joint report from EFSA and ECDC.
-
NewsCommunity spread drives ongoing measles transmission in Europe
Preliminary data for 2025 show a significant drop in the number of reported measles cases across EU/EEA countries compared with 2024. However, these figures are still twice as high than those reported in 2023.
-
NewsNipah virus outbreak: Risk of global threat is low, say experts
The Global Virus Network is monitoring reports of a Nipah virus outbreak in India and emphasizes that such cases, while very concerning and serious, are not unexpected or unprecedented.
-
NewsHalf of all people living with HIV in Europe are diagnosed late
Europe is failing to test and treat HIV early, with over half of all diagnoses in 2024 being made too late for optimal treatment, according to new data from ECDC and WHO/Europe.
-
NewsTime to act and not react: how can the European Union turn the tide of antimicrobial resistance?
Despite determined efforts by countries and healthcare professionals, Europe is not on track to meet four of the five AMR targets set by the EU Council for 2030*, according to data released on EAAD.
-
NewsStudy in Europe: monoclonal antibodies effectively prevent respiratory syncytial virus in infants
Data from Belgium, Portugal and Spain show that immunisation of children after birth reduced the risk of hospitalization due to RSV infection by almost 80%.
-
NewsRSV vaccines safe and effective, Cochrane review finds
A new Cochrane review demonstrates that vaccines for respiratory syncytial virus (RSV) are both safe and effective in protecting vulnerable groups that are most at risk of serious illness, including older adults and infants.
-
NewsDrug-resistant fungus Candidozyma auris confirmed to spread rapidly in European hospitals: ECDC calls for urgent action
The latest ECDC survey shows that case numbers are rising and outbreaks are growing in scale, with several countries reporting ongoing local transmission.
-
NewsProtecting the most vulnerable: ECDC recommendations to address ongoing local transmission of diphtheria
A new ECDC Rapid Risk Assessment highlights how ongoing circulation of diphtheria caused by Corynebacterium diphtheriae may affect some populations who are more vulnerable to infection and issues recommendations to protect those most at risk.
-
NewsNew ECDC weekly reports and guidance to tackle mosquito-borne diseases across Europe
As Europe enters this year’s mosquito season, ECDC has launched a new series of weekly epidemiological surveillance updates and public health guidance on mosquito-borne diseases.
-
NewsEvery dose counts: Safeguarding the success of vaccination in Europe
Marking European Immunization Week (EIW) 2025, a new report highlights the risks of suboptimal vaccination coverage in Europe and publishes a set of operational tools that public health authorities can use to improve vaccination acceptance and uptake.
-
NewsMeasles on the rise again in Europe: Time to check your vaccination status
Eight out of ten people who were diagnosed with measles in the EU/EEA in the last year were not vaccinated, according to a new measles and rubella update.
-
NewsUrgent action needed to keep Europe polio-free, warn heads of ECDC and WHO Europe
An unusually high amount of poliovirus detections in several European countries in recent months has underscored the importance of keeping Europe polio-free.